Erlotinib in Treating Patients With Recurrent or Metastatic Skin Squamous Cell Carcinoma
Clinical trial NCT01198028 · COMPLETED
Trial details
- NCT number
- NCT01198028
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-10
- Primary completion
- 2019-05-01
- Enrollment
- 42
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.